Antibiotic :: GSK & Anacor Pharmaceuticals form alliance to develop systemic antivirals and antibiotics
GlaxoSmithKline and Anacor Pharmaceuticals announced that they have entered into a worldwide strategic alliance for the discovery, development and commercialisation of novel medicines for viral and bacterial diseases. The collaboration provides GlaxoSmithKline access to Anacor’s proprietary boron-based chemistry for use against selected targets.